Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-24
2006-10-24
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C930S020000
Reexamination Certificate
active
07125842
ABSTRACT:
The invention relates to compounds including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity. The invention includes the use of cell cycle G2 checkpoint abrogators as anti-fungal agents, such as anti-fungal medicine.
REFERENCES:
patent: 5696078 (1997-12-01), Oppenheim et al.
patent: 2004/0248783 (2004-12-01), Kawabe et al.
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
SIGMA. Designing Custom Peptides. http://www.sigma-genosys.com/peptide—design.asp (Accessed Dec. 16, 2004).
H.J.C. Berendsen. A Glimpse of the Holy Grail? Science (1998) 282, pp. 642-643.
D. Voet and J.G. Voet. Biochemistry, 2nd Edition.(1995), pp. 235-241.
Kawabe Takumi
Kobayashi Hidetaka
Campell Bruce R.
CanBas Co. Ltd.
Heard Thoams S.
Pillsbury Winthrop Shaw & Pittman LLP
LandOfFree
Anti-fungal compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-fungal compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-fungal compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3627241